0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty]
leuprolide acetate
RxCUI: 2720348
What the CMS Formulary Data Shows for 0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty]
Per the CMS 2026 Part D formulary file, 0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty] (RxNorm concept RXCUI 2720348, generic name leuprolide acetate) appears on 7 distinct formulary files spanning 143 Medicare Part D plan offerings - 2.8% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 3 to Tier 5, with a cross-plan average of Tier 4.6.
Real-world access to 0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty] depends on utilization management as much as tier placement: 57.1% of covering formularies require prior authorization. 0% require step therapy. 14.3% apply quantity limits.
Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty] today.
Coverage Details
- Formularies covering
- 7
- Plans covering
- 143
- Coverage rate
- 2.8%
- Tier range
- Tier 3 – Tier 5
- Average tier
- Tier 5, Specialty
Restrictions
- Prior authorization required
- 57.1% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 14.3% of formularies
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering 0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty]
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is 0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty] covered by Medicare Part D?
Yes, 0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty] is covered by 143 Medicare Part D plans (2.8% of all Part D formularies).
What tier is 0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty] on Medicare Part D plans?
0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty] averages Tier 4.6 across Part D plans, ranging from Tier 3 to Tier 5.
Does 0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty] require prior authorization?
57.1% of Part D formularies require prior authorization for 0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty]. Step therapy: 0%. Quantity limits: 14.3%.
Read our methodology - how this data is sourced, computed, and verified.